SORAFENIB for Thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 399 adverse event reports in the FDA FAERS database where SORAFENIB was used for Thyroid cancer.
Most Reported Side Effects for SORAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatocellular carcinoma | 1,665 | 15.3% | 492 | 306 |
| Diarrhoea | 1,611 | 14.8% | 301 | 619 |
| Off label use | 1,587 | 14.6% | 301 | 563 |
| Fatigue | 1,041 | 9.5% | 179 | 450 |
| Palmar-plantar erythrodysaesthesia syndrome | 1,040 | 9.5% | 202 | 233 |
| Decreased appetite | 906 | 8.3% | 241 | 420 |
| Death | 904 | 8.3% | 901 | 236 |
| Asthenia | 777 | 7.1% | 231 | 415 |
| Nausea | 716 | 6.6% | 139 | 350 |
| Rash | 613 | 5.6% | 103 | 214 |
| Weight decreased | 598 | 5.5% | 144 | 274 |
| Vomiting | 544 | 5.0% | 126 | 308 |
| Hypertension | 517 | 4.7% | 95 | 178 |
| Pain in extremity | 497 | 4.6% | 65 | 182 |
| Pyrexia | 493 | 4.5% | 118 | 288 |
Other Indications for SORAFENIB
Hepatocellular carcinoma (4,986)
Hepatic cancer (1,167)
Acute myeloid leukaemia (620)
Renal cell carcinoma (454)
Product used for unknown indication (234)
Metastases to lung (182)
Renal cancer (179)
Metastatic renal cell carcinoma (134)
Neoplasm malignant (121)
Desmoid tumour (111)
Other Drugs Used for Thyroid cancer
LENVATINIB (2,668)
CABOZANTINIB S-MALATE (1,615)
VANDETANIB (591)
DABRAFENIB (583)
TRAMETINIB DIMETHYL SULFOXIDE (482)
LEVOTHYROXINE (299)
PAZOPANIB (264)
PRALSETINIB (199)
CABOZANTINIB (125)
VEMURAFENIB (119)